Filing Details
- Accession Number:
- 0001437749-24-033950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-07 16:35:48
- Reporting Period:
- 2024-11-05
- Accepted Time:
- 2024-11-07 16:35:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1561958 | Yann Echelard | 3020 Carrington Mill Blvd, Suite 475 Morrisville NC 27560 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-05 | 20,000 | $24.48 | 224,098 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.
- Includes shares of restricted Common Stock, which vest over various time periods.
Billionaire Hedge Funds
